ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) Stock Price & Overview
NASDAQ:ZYBT • KYG989MS1016
The current stock price of ZYBT is 0.75 USD. Today ZYBT is down by 0%. In the past month the price decreased by -10.76%. In the past year, price decreased by -83.33%.
ZYBT Key Statistics
- Market Cap
- 35.543M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.03
- Dividend Yield
- N/A
ZYBT Stock Performance
ZYBT Stock Chart
ZYBT Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ZYBT. When comparing the yearly performance of all stocks, ZYBT is a bad performer in the overall market: 98.4% of all stocks are doing better.
ZYBT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ZYBT. ZYBT may be in some trouble as it scores bad on both profitability and health.
ZYBT Earnings
ZYBT Forecast & Estimates
ZYBT Groups
Sector & Classification
ZYBT Financial Highlights
Over the last trailing twelve months ZYBT reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS decreased by -123.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.05% | ||
| ROE | -3.46% | ||
| Debt/Equity | 0.02 |
ZYBT Ownership
ZYBT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 28.85 | 951.275B | ||
| JNJ | JOHNSON & JOHNSON | 20.83 | 584.618B | ||
| MRK | MERCK & CO. INC. | 22.63 | 289.542B | ||
| PFE | PFIZER INC | 8.98 | 152.449B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.57 | 123.471B | ||
| ZTS | ZOETIS INC | 17.29 | 51.652B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.87 | 26.443B | ||
| VTRS | VIATRIS INC | 5.67 | 16.373B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.76 | 11.902B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.414B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.72B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.704B | ||
| AMRX | AMNEAL PHARMACEUTICALS INC | 13.59 | 4.169B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ZYBT
Company Profile
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 277 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.
Company Info
IPO: 2025-01-07
ZHENGYE BIOTECHNOLOGY HOLDIN
No.1 Lianmeng Street, Jilin Economic &, Technical Development Zone
Jilin JILIN CN
Employees: 277
ZHENGYE BIOTECHNOLOGY HOLDIN / ZYBT FAQ
What does ZHENGYE BIOTECHNOLOGY HOLDIN do?
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 277 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.
What is the stock price of ZHENGYE BIOTECHNOLOGY HOLDIN today?
The current stock price of ZYBT is 0.75 USD.
What is the dividend status of ZHENGYE BIOTECHNOLOGY HOLDIN?
ZYBT does not pay a dividend.
How is the ChartMill rating for ZHENGYE BIOTECHNOLOGY HOLDIN?
ZYBT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the market capitalization of ZYBT stock?
ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) has a market capitalization of 35.54M USD. This makes ZYBT a Nano Cap stock.